Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Skin Grafting Device Market Size & Growth Forecast 2026–2035, By Segments (Device Type, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11821| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Skin Grafting Device Market size was assessed at USD 146.17 Million in 2025 and is poised to grow at a 5.7% CAGR between 2026 and 2035, attaining USD 254.45 Million by 2035. The industry revenue for 2026 is estimated at USD 153.41 million.

Base Year Value (2025)
USD 146.17 Million
CAGR (2026-2035)
5.7%
Forecast Year Value (2035)
USD 254.45 Million
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Skin Grafting Device Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 52.31% market share in 2025, supported by advanced surgical infrastructure, broad use of specialized grafting devices, and consistent demand from burn, trauma, and chronic wound procedures.
  • Asia Pacific is projected to grow at a 6.44% CAGR as expanding hospital capacity, improved reconstructive care access, and rising surgical volumes accelerate adoption of advanced grafting devices.

Segment Momentum

  • Dermatomes lead with 77.9% share due to their essential role in consistent graft harvesting and procedural control in burn and reconstructive surgeries, making them central to routine clinical workflows.
  • Chronic Wound Care is the fastest-growing segment as demand rises for more effective long-term wound closure solutions, expanding grafting device use beyond acute burn treatment into persistent wound management pathways.

Market Expansion Drivers

  • Rising incidence of severe burn injuries increasing demand for advanced skin grafting procedures.
  • Government reimbursement support improving patient access to sophisticated wound treatment technologies.
  • Advancements in regenerative medicine and bioengineered skin grafts enhancing reconstructive treatment outcomes.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent companies in the skin grafting device market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), B. Braun SE (Germany), Integra LifeSciences Holdings Corporation (United States), Mölnlycke Health Care AB (Sweden), De Soutter Medical Ltd. (United Kingdom), Exsurco Medical, Inc. (United States), NOUVAG AG (Switzerland), Aygün Surgical Instruments Co., Inc. (Turkey), Rudolf Storz GmbH (Germany).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising incidence of severe burn injuries increasing demand for advanced skin grafting procedures

A growing volume of deep partial-thickness and full-thickness burns is pushing hospitals and trauma centers to adopt more efficient harvesting, meshing, and graft expansion systems that can accelerate surgical intervention and improve wound coverage. In the skin grafting device market, severe burn cases create immediate procedural demand because clinicians often need reliable tools that reduce operating time, optimize the use of limited donor skin, and support better graft take in critical care settings. This transitions purchasing toward advanced skin grafting devices used in specialized burn units, where treatment complexity, infection risk, and the need for functional and cosmetic recovery directly influence procurement decisions.

Government reimbursement support improving patient access to sophisticated wound treatment technologies

When reimbursement frameworks cover advanced wound closure and grafting procedures more effectively, providers face fewer financial barriers to using higher-cost skin grafting technologies in routine care. In the skin grafting device market, this changes treatment behavior by making sophisticated graft preparation and application devices more viable not only for major surgical centers but also for a broader range of hospitals managing chronic wounds, trauma, and reconstructive cases. The result is stronger procedural adoption, as clinicians can select devices based more on clinical suitability and expected healing performance rather than limiting choices to the lowest upfront-cost options.

Advancements in regenerative medicine and bioengineered skin grafts enhancing reconstructive treatment outcomes

Progress in regenerative medicine is reshaping treatment protocols by increasing the clinical value of precise graft handling, delivery, and integration techniques, which raises demand for devices compatible with newer bioengineered materials and reconstructive workflows. In the skin grafting device market, the emergence of bioactive and tissue-engineered graft options is influencing market adoption toward systems that support controlled application, minimize tissue damage, and improve consistency during complex reconstruction. This is supporting market development as surgeons and specialty wound care teams align device selection with therapies designed to improve healing quality, reduce complications, and achieve better functional restoration.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising incidence of severe burn injuries increasing demand for advanced skin grafting procedures 2.10% High North America, Asia Pacific High Near Term
Government reimbursement support improving patient access to sophisticated wound treatment technologies 1.80% High Europe, North America High Mid Term
Advancements in regenerative medicine and bioengineered skin grafts enhancing reconstructive treatment outcomes 1.50% High North America, Europe Emerging Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
52.31% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 52.31% share of the skin grafting device market. This leadership is underpinned by the region’s established surgical infrastructure, broad availability of advanced wound care and reconstructive procedures, and consistent use of specialized devices across hospital and ambulatory settings. Market activity is strengthened by the routine clinical management of burn injuries, chronic wounds, and trauma cases, where providers are more likely to adopt device-assisted grafting approaches that support procedural efficiency and treatment precision.

Asia Pacific is projected to expand at a 6.44% CAGR over the forecast period in the skin grafting device market, driven by rising procedural volumes and broader adoption of surgical wound management technologies across developing healthcare systems. Growth is being propelled by improving access to reconstructive and burn care, increasing hospital capacity, and a larger patient base requiring skin repair interventions. As treatment availability widens and providers invest in more capable surgical equipment, device uptake is accelerating in practical care settings where demand for efficient graft preparation and application continues to rise.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Surgical Precision Focus

Germany emphasizes skin grafting devices that deliver consistent graft quality and procedural precision in reconstructive and trauma surgery. Hospitals are investing in technologies that streamline surgical workflows while supporting specialized wound care practices.

France 🇫🇷

Specialized Hospital Adoption

France is expanding the use of skin grafting devices in specialized hospitals managing burns and complex wounds. The market values solutions that simplify surgical handling and contribute to standardized treatment protocols across clinical settings.

Italy 🇮🇹

Clinical Workflow Efficiency

Italy integrates skin grafting devices into reconstructive surgery and wound management programs to improve procedural consistency. Medical facilities prioritize user-friendly equipment that enhances surgical efficiency while supporting diverse patient care requirements.

Japan 🇯🇵

Minimally Invasive Techniques

Japan is advancing the use of skin grafting devices that enhance precision while minimizing tissue trauma. Clinical demand favors compact, reliable systems that integrate with modern surgical practices and improve efficiency in reconstructive procedures.

South Korea 🇰🇷

Reconstructive Care Innovation

South Korea utilizes skin grafting devices across reconstructive, cosmetic, and burn treatment settings. Healthcare providers seek technologies that improve graft consistency, shorten procedure times, and support high-quality patient care.

United States 🇺🇸

Advanced Wound Care

The U.S. skin grafting device market is supported by increasing adoption of advanced wound management and reconstructive procedures. Healthcare providers prioritize devices that improve procedural efficiency, reduce operating time, and support better clinical outcomes in burn and chronic wound treatment.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Skin Grafting Device Market Share (%), Device Type, 2025

Dermatomes
Meshers
Accessories

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Device Type Segment Analysis: Dermatomes (Largest Segment) vs Meshers (Fastest-Growing Segment)

Dermatomes held a 77.9% share of the skin grafting device market in 2025, reflecting their central role in harvesting grafts with the consistency and procedural control required in reconstructive and burn-related surgeries. Their leadership is underpinned by the fact that graft harvesting is a fundamental step in skin grafting procedures, making dermatomes indispensable across routine clinical workflows. This strong installed use base, combined with their direct relevance to procedural precision and operating efficiency, keeps Dermatomes at the core of demand in the skin grafting device market.

Meshers represent the fastest-growing segment in the skin grafting device market as providers increasingly prioritize techniques that help extend available graft material and improve coverage efficiency in demanding wound management settings. Their momentum is closely tied to practical surgical needs, especially where maximizing graft utilization can support treatment of larger or more complex wound areas. Compared with alternative device types that serve more established procedural steps, Meshers are gaining traction because they address a clear operational need in graft expansion and resource optimization.

Application Segment Analysis: Burn Care (Largest Segment) vs Chronic Wound Care (Fastest-Growing Segment)

Within the skin grafting device market, Burn Care accounted for a 47.51% share in 2025, supported by the frequent need for grafting procedures in moderate-to-severe burn treatment. This segment retains leadership because burn injuries often require timely surgical intervention, including wound closure and skin restoration, which sustains consistent demand for grafting devices in acute care settings. The procedural intensity and clinical urgency associated with burn management continue to underpin Burn Care’s leading share in the skin grafting device market.

Chronic Wound Care is the fastest-growing application in the skin grafting device market, encouraged by rising clinical attention on wounds that are difficult to heal through conventional treatment alone. Its growth is being supported by the practical need for more effective closure strategies in persistent wound cases, where prolonged healing times can increase treatment complexity. Relative to more established applications, Chronic Wound Care is gaining momentum because it expands the use of grafting devices into longer-duration care pathways where clinicians are seeking more definitive intervention options.

Segment Sub-Segment Largest Segment Fastest Growing
Device Type Dermatomes, Meshers, Accessories Dermatomes Meshers
Application Burn Care, Chronic Wound Care, Reconstructive Surgery Burn Care Chronic Wound Care
End-use Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Dermatology Clinics Hospitals Ambulatory Surgical Centers
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the skin grafting device market:

1. Zimmer Biomet Holdings Inc. (United States)

2. Stryker Corporation (United States)

3. B. Braun SE (Germany)

4. Integra LifeSciences Holdings Corporation (United States)

5. Mölnlycke Health Care AB (Sweden)

6. De Soutter Medical Ltd. (United Kingdom)

7. Exsurco Medical Inc. (United States)

8. NOUVAG AG (Switzerland)

9. Aygün Surgical Instruments Co. Inc. (Turkey)

10. Rudolf Storz GmbH (Germany)

The skin grafting device market is witnessing innovation driven by demand for minimally invasive wound treatment solutions and advanced tissue regeneration technologies. Manufacturers are focusing on improving graft precision, healing efficiency, and surgical ease through the use of automated and portable devices. Rising incidence of burn injuries and chronic wounds is also encouraging ongoing product development across the market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
CUTISS AG Oct-24 CUTISS AG successfully performed the first U.S.-based grafting procedure of denovoSkin, an autologous bio-engineered skin graft, at Massachusetts General Hospital. Conducted under an FDA single-patient Investigational New Drug application, this milestone represents a strategic advancement in regenerative medicine and demonstrates the clinical feasibility of personalized, bio-engineered tissue therapies for complex reconstructive burn treatment.
Medline Mar-24 The FDA approved the Medline Autologous Regeneration of Tissue (ART) Skin Harvesting System, a semi-automated handheld device for micrograft application. By utilizing needle-based harvesting rather than traditional blades, the device enables minimally invasive procedures under local anesthesia, expanding the capability for skin regeneration in clinical settings and diversifying the technological options available for wound care.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Skin Grafting Device Market — Custom Segments

Segment Sub-Segment
No segment data available.

Skin Grafting Device Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the skin grafting device market?

The market valuation of the skin grafting device is USD 153.41 million in 2026.

What is the anticipated CAGR of the skin grafting device industry?

Skin Grafting Device Market size is anticipated to rise from USD 146.17 million in 2025 to USD 254.45 million by 2035 reflecting a CAGR surpassing 5.7% over the forecast horizon of 2026-2035.

How is rising incidence of severe burn injuries influencing demand for advanced skin grafting devices?

Increasing burn cases are driving hospitals toward faster harvesting, meshing, and graft expansion systems that reduce operating time and improve coverage efficiency. Procurement is increasingly focused on devices that optimize limited donor skin and support better graft success in critical care environments.

How are reimbursement frameworks affecting adoption of skin grafting technologies?

Improved reimbursement support is enabling wider adoption beyond major surgical centers by reducing cost sensitivity. Hospitals can prioritize clinically effective grafting systems, increasing procedural uptake and encouraging use based on healing outcomes rather than upfront equipment cost constraints.

Why do dermatomes dominate the skin grafting device market?

Dermatomes lead with 77.9% share due to their essential role in consistent graft harvesting and procedural control in burn and reconstructive surgeries, making them central to routine clinical workflows.

What is driving growth in chronic wound care within the skin grafting device market?

Chronic Wound Care is the fastest-growing segment as demand rises for more effective long-term wound closure solutions, expanding grafting device use beyond acute burn treatment into persistent wound management pathways.

Why does North America lead the skin grafting device market?

North America held a 52.31% market share in 2025, supported by advanced surgical infrastructure, broad use of specialized grafting devices, and consistent demand from burn, trauma, and chronic wound procedures.

What is driving skin grafting device market growth in Asia Pacific?

Asia Pacific is projected to grow at a 6.44% CAGR as expanding hospital capacity, improved reconstructive care access, and rising surgical volumes accelerate adoption of advanced grafting devices.

Who are the major participants shaping the skin grafting device landscape?

Prominent companies in the skin grafting device market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), B. Braun SE (Germany), Integra LifeSciences Holdings Corporation (United States), Mölnlycke Health Care AB (Sweden), De Soutter Medical Ltd. (United Kingdom), Exsurco Medical, Inc. (United States), NOUVAG AG (Switzerland), Aygün Surgical Instruments Co., Inc. (Turkey), Rudolf Storz GmbH (Germany).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →